Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA
PRESS RELEASE April 22, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that…
Pharmaceuticals, Biotechnology and Life Sciences
PRESS RELEASE April 22, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that…
Updated results will be presented from ASPEN-01, the ongoing Phase 1b Study of ALX148 in combination trastuzumab, ramucirumab and paclitaxel in…
PRA offers post-authorization safety solutions to keep up with the speed of COVID-19 vaccine and therapeutic pharmacovigilance requirementsRALEIGH, N.C., April…
COPENHAGEN, Denmark, April 21, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative…
LONDON, April 21, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology…
NEWS RELEASE – REGULATED INFORMATION 21 April 2021, 10:00 p.m. CET IRVINE, CA, and HERSTAL, BELGIUM – 21 April 2021 – MDxHealth…
ASGCT and ISCT abstracts highlight the Company’s progress with gene circuit-engineered allogeneic CAR-NK cell therapy pipelineSOUTH SAN FRANCISCO, Calif., April…
Saint-Herblain (France), April 21, 2021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic…
Basel, Switzerland, April 21, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that shareholders approved all proposals of the board…
Several major clinical milestones achieved in 2020 by AsiDNA™, including promising initial results in combination with chemotherapy and the launch…